معرفی
May Khanna is an Associate Professor in the Department of Pharmacology & Therapeutics at the University of Florida College of Medicine and serves as the inaugural Assistant Dean for Entrepreneurship and Innovation. Her research focuses on developing small molecule therapeutics for neurodegenerative diseases such as ALS, Alzheimer’s, and Batten disease. She bridges academia and industry to accelerate drug discovery, with a particular emphasis on preclinical drug development and protein interaction modulation.
Her grants include roles as Principal Investigator for projects funded by the National Institutes of Health (NINDS), U.S. Army Medical Research Acquisition Activity, and the ForeBatten Foundation. These grants target TDP-43 protein interactions, novel degraders for ALS, and Batten disease therapeutics. She also leads efforts in developing blood-brain barrier-impenetrable drugs for metabolic disorders.
- Education: Ph.D. in Pharmacology (not explicitly stated, inferred from title)
- Key Research Areas: TDP-43 biology, CRMP2 regulation, small molecule inhibitors, neuroprotective agents
May Khanna’s scientific contributions span over 50 peer-reviewed articles, emphasizing molecular mechanisms of neurodegeneration and translational drug development. She is committed to fostering entrepreneurship in academic research to commercialize scientific innovations.
She currently holds the business address at PO Box 100267, Gainesville, FL 32610.
